Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318532 · ClinicalTrials.gov registry record · NA
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women
A NA study of HIV Prevention Program, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 745
- Enrollment target
- 1
- Study location
NCT07318532: Completed NA study of HIV Prevention Program, sponsored by Medstar Health Research Institute.
NCT07318532 is a NA study of HIV Prevention Program that has completed, run by Medstar Health Research Institute. The registered enrollment target is 745 participants, above the 225-participant average among 3 other HIV Prevention Program trials with a reported enrollment target (231% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07318532, a NA study of HIV Prevention Program, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 745 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the "PrEP CGW" pilot study is evaluate the feasibility and acceptability of a clinic-level intervention to improve HIV prevention and Pre-exposure Prophylaxis (PrEP) services for women. The intervention includes clinic wide trainings, provider and clinic staff tool kits, PrEP navigation, and patient-facing educational resources. The overarching goal of the program is to determine if the intervention improves PrEP uptake among women. Patients who attend the study-site clinic will be exposed to the intervention. Patients will be invited to participate in post-visit questionnaires; approximately 20 patients will be invited to participate in interviews.
Primary Outcome
* Percentage of eligible patients who received introduction to pre-exposure prophylaxis (PrEP) by navigators (by comparison of the navigators counseling log to the electronic health record (EHR) * Percentage of eligible patients counseled about PrEP by providers (by EHR review) * Percentage of eligible patients counseled by either the PrEP navigator or a provider
Conditions Studied
Interventions
- BEHAVIORAL The women's PrEP Project (W-PrEP)
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 745 participants |
| Start Date | 2023-01-02 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT07318532 record still lists
NCT07318532 is an interventional study that assigns participants to a tested intervention. The registered 745 participants enrollment target is mid-sized for trials with a published cap, above the 225-participant average among 3 other HIV Prevention Program trials with a reported enrollment target (231% higher).
The record links to 1 condition, with HIV Prevention Program appearing as the primary indexed condition, and to 1 intervention - of which The women's PrEP Project (W-PrEP) is the first listed.
NCT07318532 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07318532 about?
NCT07318532 is a clinical study titled "Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women". The goal of the "PrEP CGW" pilot study is evaluate the feasibility and acceptability of a clinic-level intervention to improve HIV prevention and Pre-exposure Prophylaxis (PrEP) services for women. The intervention includes clinic wide trainings, provider and clinic staff tool kits, PrEP navigation,...
What is the current status of trial NCT07318532?
This trial is currently completed. It is a NA study. The enrollment target is 745 participants. The study started on 2023-01-02. Estimated completion is 2024-06-30.
What conditions does trial NCT07318532 study?
This clinical trial studies the following conditions: HIV Prevention Program.
What interventions are being tested in trial NCT07318532?
The interventions under investigation include: The women's PrEP Project (W-PrEP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07318532?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07318532 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention Program
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
RECRUITING · NA
-
Testing of the Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs Program
COMPLETED · NA
-
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI